Save information for later
Sign Up

Learn About Acute Interstitial Pneumonia

What is the definition of Acute Interstitial Pneumonia?
Acute interstitial pneumonia (AIP) is a rare and serious condition that affects the lungs. The signs and symptoms generally develop and progress rapidly. In the early stages of the condition, affected people may experience upper respiratory and/or viral-like symptoms such as cough, shortness of breath, and fever. This is followed by the rapid onset of respiratory failure and the need for mechanical ventilation in the majority of cases. The underlying cause of AIP is unknown. Most cases occur sporadically in people with no family history of the condition.
What are the alternative names for Acute Interstitial Pneumonia?
  • Acute interstitial pneumonia
  • Acute interstitial pneumonitis
  • Hamman-Rich syndrome
Who are the top Acute Interstitial Pneumonia Local Doctors?
Elite in Acute Interstitial Pneumonia
Pulmonary Medicine | Intensive Care Medicine
Elite in Acute Interstitial Pneumonia
Pulmonary Medicine | Intensive Care Medicine

Inova Health Care Services

3300 Gallows Rd, 
Falls Church, VA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Steven Nathan is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Falls Church, Virginia. Dr. Nathan is rated as an Elite provider by MediFind in the treatment of Acute Interstitial Pneumonia. His top areas of expertise are Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Prostatectomy. Dr. Nathan is currently accepting new patients.

Elite in Acute Interstitial Pneumonia
Pulmonary Medicine
Elite in Acute Interstitial Pneumonia
Pulmonary Medicine

USC Care Medical Group Inc

1500 San Pablo St, 
Los Angeles, CA 
Languages Spoken:
English
Offers Telehealth

Toby Maher is a Pulmonary Medicine provider in Los Angeles, California. Dr. Maher is rated as an Elite provider by MediFind in the treatment of Acute Interstitial Pneumonia. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Lung Transplant, and Tissue Biopsy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Acute Interstitial Pneumonia
Pulmonary Medicine
Elite in Acute Interstitial Pneumonia
Pulmonary Medicine

University Of Virginia Physicians Group

1215 Lee St, 
Charlottesville, VA 
Languages Spoken:
English, Hebrew
Accepting New Patients
Offers Telehealth

Imre Noth is a Pulmonary Medicine provider in Charlottesville, Virginia. Dr. Noth is rated as an Elite provider by MediFind in the treatment of Acute Interstitial Pneumonia. His top areas of expertise are Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Acute Interstitial Pneumonia, Lung Transplant, and Gastrostomy. Dr. Noth is currently accepting new patients.

What are the latest Acute Interstitial Pneumonia Clinical Trials?
Low Dose Danazol for the Treatment of Telomere Related Diseases

Background: DNA is a structure in the body. It contains data about how the body develops and works. Telomeres are found on the end of chromosomes in DNA. Some people with short telomeres or other gene changes can develop diseases of the bone marrow, lung, and liver. Researchers want to see if low doses of the hormone drug danazol can help.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial Evaluating the Efficacy and Safety of 2 Doses of Buloxibutid Over 52 Weeks in People With Idiopathic Pulmonary Fibrosis.

Summary: The ASPIRE trial is a 52 week randomized, double-blind, placebo-controlled, parallel-group, multicenter trial in which the efficacy, safety, and pharmacokinetics of orally administered buloxibutid, either on top of stable IPF therapy or as monotherapy, are assessed in participants with IPF. Trial website: www.aspire-ipf.com

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Acute Interstitial Pneumonia?